Cargando…
Myelodysplastic syndrome with synchronous gastric cancer: when the symptoms suggest something else
Although myelodysplastic syndromes have a clear definition in theory, the morphologic dysplasia associated with ineffective hematopoiesis may be subtle and difficult to recognize and can commonly be mimicked by systemic conditions, such as infections, autoimmune disorders, nutritional deficiencies,...
Autores principales: | de Melo Campos, Paula, Traina, Fabiola, Lorand-Metze, Irene, Olalla Saad, Sara Teresinha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Hematologia e Hemoterapia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318472/ https://www.ncbi.nlm.nih.gov/pubmed/25453656 http://dx.doi.org/10.1016/j.bjhh.2014.07.005 |
Ejemplares similares
-
IRAK1 expression in bone marrow cells does not impact patient outcomes in myelodysplastic syndromes
por: de Melo Campos, Paula, et al.
Publicado: (2018) -
Immunophenotyping in Myelodysplastic Syndromes Can Add Prognostic Information to Well-Established and New Clinical Scores
por: Reis-Alves, Suiellen C., et al.
Publicado: (2013) -
Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes
por: Machado-Neto, João Agostinho, et al.
Publicado: (2011) -
Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors
por: Reis-Alves, Suiellen C, et al.
Publicado: (2015) -
Low Ten-eleven-translocation 2 (TET2) transcript level is independent of TET2 mutation in patients with myeloid neoplasms
por: Scopim-Ribeiro, Renata, et al.
Publicado: (2016)